APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cat Medicines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cat Medicines Industry Growth and Trends Forecast to 2032

28 December 2025115 pages

Choose your research edition.

Industry ResearchCat Medicines Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Cat Medicines Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Cat Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cat Medicines Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Cat Medicines Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Cat Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cat Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cat Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cat Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cat Medicines include Wuhan Chopperlvya Animal Health, Zoetis, Tianjin Ringpu Bio-technology, Nanjing Jindun Animal Pharmaceutical, Jining Wanhe Biotechnology (Belcol), Pfizer, Harbin Pharmaceutical Group, Taizhou Boleideli Biotechnology and Virbac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cat Medicines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cat Medicines market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cat Medicines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cat Medicines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cat Medicines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cat Medicines Market by Company

Wuhan Chopperlvya Animal Health

Zoetis

Tianjin Ringpu Bio-technology

Nanjing Jindun Animal Pharmaceutical

Jining Wanhe Biotechnology (Belcol)

Pfizer

Harbin Pharmaceutical Group

Taizhou Boleideli Biotechnology

Virbac

Vetoquinol

Merck

IDEXX

Elanco

Dechra Veterinary Products

Ceva

Boehringer Ingelheim

Cat Medicines Segment by Type

Antiparasitic Drugs

Dermatological Drugs

Digestive System Drugs

Others

Cat Medicines Segment by Application

Online

Offline

Cat Medicines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cat Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cat Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cat Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cat Medicines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cat Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antiparasitic Drugs Table 2. Major Company of Dermatological Drugs Table 3. Major Company of Digestive System Drugs Table 4. Major Company of Others Table 5. Global Cat Medicines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Cat Medicines Sales by Type (2021-2026) & (Tons) Table 7. Global Cat Medicines Sales Market Share in Volume by Type (2021-2026) Table 8. Global Cat Medicines Sales by Type (2021-2026) & (US$ Million) Table 9. Global Cat Medicines Sales Market Share in Value by Type (2021-2026) Table 10. Global Cat Medicines Price by Type (2021-2026) & (US$/Ton) Table 11. Global Cat Medicines Sales by Type (2027-2032) & (Tons) Table 12. Global Cat Medicines Sales Market Share in Volume by Type (2027-2032) Table 13. Global Cat Medicines Sales by Type (2027-2032) & (US$ Million) Table 14. Global Cat Medicines Sales Market Share in Value by Type (2027-2032) Table 15. Global Cat Medicines Price by Type (2027-2032) & (US$/Ton) Table 16. North America Cat Medicines Sales by Type (2021-2026) & (Tons) Table 17. North America Cat Medicines Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Cat Medicines Sales by Type (2021-2026) & (Tons) Table 19. Europe Cat Medicines Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Cat Medicines Sales by Type (2021-2026) & (Tons) Table 21. Asia-Pacific Cat Medicines Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Cat Medicines Sales by Type (2021-2026) & (Tons) Table 23. Latin America Cat Medicines Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Cat Medicines Sales by Type (2021-2026) & (Tons) Table 25. Middle East and Africa Cat Medicines Sales by Type (2021-2026) & (US$ Million) Table 26. Cat Medicines Industry Trends Table 27. Cat Medicines Industry Drivers Table 28. Cat Medicines Industry Opportunities and Challenges Table 29. Cat Medicines Industry Restraints Table 30. Global Cat Medicines Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Cat Medicines Revenue Market Share by Company (2021-2026) Table 32. Global Cat Medicines Sales by Company (2021-2026) & (Tons) Table 33. Global Cat Medicines Sales Share by Company (2021-2026) Table 34. Global Cat Medicines Market Price by Company (2021-2026) & (US$/Ton) Table 35. Global Cat Medicines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Cat Medicines Major Company Production Sites and Headquarters Table 37. Global Cat Medicines Company, Product Type & Application Table 38. Global Cat Medicines Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Cat Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Cat Medicines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Cat Medicines Sales by Region (2021-2026) & (Tons) Table 43. Global Cat Medicines Sales Market Share in Volume by Region (2021-2026) Table 44. Global Cat Medicines Sales by Region (2021-2026) & (US$ Million) Table 45. Global Cat Medicines Sales Market Share in Value by Region (2021-2026) Table 46. Global Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 47. Global Cat Medicines Sales by Region (2027-2032) & (Tons) Table 48. Global Cat Medicines Sales Market Share in Volume by Region (2027-2032) Table 49. Global Cat Medicines Sales by Region (2027-2032) & (US$ Million) Table 50. Global Cat Medicines Sales Market Share in Value by Region (2027-2032) Table 51. Global Cat Medicines Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 52. Global Cat Medicines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Cat Medicines Sales by Application (2021-2026) & (Tons) Table 54. Global Cat Medicines Sales Market Share in Volume by Application (2021-2026) Table 55. Global Cat Medicines Sales by Application (2021-2026) & (US$ Million) Table 56. Global Cat Medicines Sales Market Share in Value by Application (2021-2026) Table 57. Global Cat Medicines Price by Application (2021-2026) & (US$/Ton) Table 58. Global Cat Medicines Sales by Application (2027-2032) & (Tons) Table 59. Global Cat Medicines Sales Market Share in Volume by Application (2027-2032) Table 60. Global Cat Medicines Sales by Application (2027-2032) & (US$ Million) Table 61. Global Cat Medicines Sales Market Share in Value by Application (2027-2032) Table 62. Global Cat Medicines Price by Application (2027-2032) & (US$/Ton) Table 63. North America Cat Medicines Sales by Application (2021-2026) & (Tons) Table 64. North America Cat Medicines Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Cat Medicines Sales by Application (2021-2026) & (Tons) Table 66. Europe Cat Medicines Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Cat Medicines Sales by Application (2021-2026) & (Tons) Table 68. Asia-Pacific Cat Medicines Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Cat Medicines Sales by Application (2021-2026) & (Tons) Table 70. Latin America Cat Medicines Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Cat Medicines Sales by Application (2021-2026) & (Tons) Table 72. Middle East and Africa Cat Medicines Sales by Application (2021-2026) & (US$ Million) Table 73. Wuhan Chopperlvya Animal Health Company Information Table 74. Wuhan Chopperlvya Animal Health Business Overview Table 75. Wuhan Chopperlvya Animal Health Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Wuhan Chopperlvya Animal Health Cat Medicines Product Portfolio Table 77. Wuhan Chopperlvya Animal Health Recent Development Table 78. Zoetis Company Information Table 79. Zoetis Business Overview Table 80. Zoetis Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Zoetis Cat Medicines Product Portfolio Table 82. Zoetis Recent Development Table 83. Tianjin Ringpu Bio-technology Company Information Table 84. Tianjin Ringpu Bio-technology Business Overview Table 85. Tianjin Ringpu Bio-technology Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Tianjin Ringpu Bio-technology Cat Medicines Product Portfolio Table 87. Tianjin Ringpu Bio-technology Recent Development Table 88. Nanjing Jindun Animal Pharmaceutical Company Information Table 89. Nanjing Jindun Animal Pharmaceutical Business Overview Table 90. Nanjing Jindun Animal Pharmaceutical Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Nanjing Jindun Animal Pharmaceutical Cat Medicines Product Portfolio Table 92. Nanjing Jindun Animal Pharmaceutical Recent Development Table 93. Jining Wanhe Biotechnology (Belcol) Company Information Table 94. Jining Wanhe Biotechnology (Belcol) Business Overview Table 95. Jining Wanhe Biotechnology (Belcol) Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Jining Wanhe Biotechnology (Belcol) Cat Medicines Product Portfolio Table 97. Jining Wanhe Biotechnology (Belcol) Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Pfizer Cat Medicines Product Portfolio Table 102. Pfizer Recent Development Table 103. Harbin Pharmaceutical Group Company Information Table 104. Harbin Pharmaceutical Group Business Overview Table 105. Harbin Pharmaceutical Group Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Harbin Pharmaceutical Group Cat Medicines Product Portfolio Table 107. Harbin Pharmaceutical Group Recent Development Table 108. Taizhou Boleideli Biotechnology Company Information Table 109. Taizhou Boleideli Biotechnology Business Overview Table 110. Taizhou Boleideli Biotechnology Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Taizhou Boleideli Biotechnology Cat Medicines Product Portfolio Table 112. Taizhou Boleideli Biotechnology Recent Development Table 113. Virbac Company Information Table 114. Virbac Business Overview Table 115. Virbac Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Virbac Cat Medicines Product Portfolio Table 117. Virbac Recent Development Table 118. Vetoquinol Company Information Table 119. Vetoquinol Business Overview Table 120. Vetoquinol Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Vetoquinol Cat Medicines Product Portfolio Table 122. Vetoquinol Recent Development Table 123. Merck Company Information Table 124. Merck Business Overview Table 125. Merck Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Merck Cat Medicines Product Portfolio Table 127. Merck Recent Development Table 128. IDEXX Company Information Table 129. IDEXX Business Overview Table 130. IDEXX Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. IDEXX Cat Medicines Product Portfolio Table 132. IDEXX Recent Development Table 133. Elanco Company Information Table 134. Elanco Business Overview Table 135. Elanco Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. Elanco Cat Medicines Product Portfolio Table 137. Elanco Recent Development Table 138. Dechra Veterinary Products Company Information Table 139. Dechra Veterinary Products Business Overview Table 140. Dechra Veterinary Products Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Dechra Veterinary Products Cat Medicines Product Portfolio Table 142. Dechra Veterinary Products Recent Development Table 143. Ceva Company Information Table 144. Ceva Business Overview Table 145. Ceva Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. Ceva Cat Medicines Product Portfolio Table 147. Ceva Recent Development Table 148. Boehringer Ingelheim Company Information Table 149. Boehringer Ingelheim Business Overview Table 150. Boehringer Ingelheim Cat Medicines Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 151. Boehringer Ingelheim Cat Medicines Product Portfolio Table 152. Boehringer Ingelheim Recent Development Table 153. North America Cat Medicines Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 154. North America Cat Medicines Sales by Country (2021-2026) & (Tons) Table 155. North America Cat Medicines Sales Market Share by Country (2021-2026) Table 156. North America Cat Medicines Sales Forecast by Country (2027-2032) & (Tons) Table 157. North America Cat Medicines Sales Market Share Forecast by Country (2027-2032) Table 158. North America Cat Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Cat Medicines Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Cat Medicines Market Share by Country (2021-2026) Table 161. North America Cat Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Cat Medicines Market Share Forecast by Country (2027-2032) Table 163. Europe Cat Medicines Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 164. Europe Cat Medicines Sales by Country (2021-2026) & (Tons) Table 165. Europe Cat Medicines Sales Market Share by Country (2021-2026) Table 166. Europe Cat Medicines Sales Forecast by Country (2027-2032) & (Tons) Table 167. Europe Cat Medicines Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Cat Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Cat Medicines Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Cat Medicines Market Share by Country (2021-2026) Table 171. Europe Cat Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Cat Medicines Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Cat Medicines Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Cat Medicines Sales by Country (2021-2026) & (Tons) Table 175. Asia-Pacific Cat Medicines Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Cat Medicines Sales Forecast by Country (2027-2032) & (Tons) Table 177. Asia-Pacific Cat Medicines Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Cat Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Cat Medicines Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Cat Medicines Market Share by Country (2021-2026) Table 181. Asia-Pacific Cat Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Cat Medicines Market Share Forecast by Country (2027-2032) Table 183. Latin America Cat Medicines Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 184. Latin America Cat Medicines Sales by Country (2021-2026) & (Tons) Table 185. Latin America Cat Medicines Sales Market Share by Country (2021-2026) Table 186. Latin America Cat Medicines Sales Forecast by Country (2027-2032) & (Tons) Table 187. Latin America Cat Medicines Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Cat Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Cat Medicines Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Cat Medicines Market Share by Country (2021-2026) Table 191. Latin America Cat Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Cat Medicines Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Cat Medicines Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Cat Medicines Sales by Country (2021-2026) & (Tons) Table 195. Middle East and Africa Cat Medicines Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Cat Medicines Sales Forecast by Country (2027-2032) & (Tons) Table 197. Middle East and Africa Cat Medicines Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Cat Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Cat Medicines Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Cat Medicines Market Share by Country (2021-2026) Table 201. Middle East and Africa Cat Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Cat Medicines Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Cat Medicines Distributors List Table 206. Cat Medicines Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Cat Medicines Image Figure 2. Global Cat Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cat Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global Cat Medicines Sales (2021-2032) & (Tons) Figure 5. Antiparasitic Drugs Image Figure 6. Global Antiparasitic Drugs Sales YoY Growth (2021-2032) & (Tons) Figure 7. Dermatological Drugs Image Figure 8. Global Dermatological Drugs Sales YoY Growth (2021-2032) & (Tons) Figure 9. Digestive System Drugs Image Figure 10. Global Digestive System Drugs Sales YoY Growth (2021-2032) & (Tons) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 13. Global Cat Medicines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Cat Medicines Market Share by Type 2025 VS 2032 Figure 15. North America Cat Medicines Sales Market Share in Volume by Type in 2025 Figure 16. North America Cat Medicines Sales Market Share in Value by Type in 2025 Figure 17. Europe Cat Medicines Sales Market Share in Volume by Type in 2025 Figure 18. Europe Cat Medicines Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Cat Medicines Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Cat Medicines Sales Market Share in Value by Type in 2025 Figure 21. Latin America Cat Medicines Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Cat Medicines Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Cat Medicines Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Cat Medicines Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Cat Medicines Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Online Image Figure 28. Global Online Sales YoY Growth (2021-2032) & (Tons) Figure 29. Offline Image Figure 30. Global Offline Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Cat Medicines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cat Medicines Market Share by Application 2025 VS 2032 Figure 33. North America Cat Medicines Sales Market Share in Volume by Application in 2025 Figure 34. North America Cat Medicines Sales Market Share in Value by Application in 2025 Figure 35. Europe Cat Medicines Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cat Medicines Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cat Medicines Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cat Medicines Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cat Medicines Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cat Medicines Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cat Medicines Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cat Medicines Sales Market Share in Value by Application in 2025 Figure 43. North America Cat Medicines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Cat Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cat Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cat Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cat Medicines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Cat Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cat Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cat Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cat Medicines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Cat Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cat Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cat Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cat Medicines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Cat Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cat Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cat Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cat Medicines Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Cat Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cat Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cat Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cat Medicines Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cat Medicines Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Antiparasitic Drugs
  • Dermatological Drugs
  • Digestive System Drugs
  • Others
Applications
  • Online
  • Offline
Companies covered
  • Wuhan Chopperlvya Animal Health
  • Zoetis
  • Tianjin Ringpu Bio-technology
  • Nanjing Jindun Animal Pharmaceutical
  • Jining Wanhe Biotechnology (Belcol)
  • Pfizer
  • Harbin Pharmaceutical Group
  • Taizhou Boleideli Biotechnology
  • Virbac
  • Vetoquinol
  • Merck
  • IDEXX
  • Elanco
  • Dechra Veterinary Products
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cat Medicines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cat Medicines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cat Medicines Market by Type
  6. 1.3.1 Antiparasitic Drugs
  7. 1.3.2 Dermatological Drugs
  8. 1.3.3 Digestive System Drugs
  9. 1.3.4 Others
  10. 1.4 Global Cat Medicines Market Size by Type
  11. 1.4.1 Global Cat Medicines Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Cat Medicines Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Cat Medicines Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Cat Medicines Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Cat Medicines Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Cat Medicines Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Cat Medicines Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Cat Medicines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cat Medicines Industry Trends
  2. 2.2 Cat Medicines Industry Drivers
  3. 2.3 Cat Medicines Industry Opportunities and Challenges
  4. 2.4 Cat Medicines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cat Medicines Revenue (2021-2026)
  2. 3.2 Global Top Players by Cat Medicines Sales (2021-2026)
  3. 3.3 Global Top Players by Cat Medicines Price (2021-2026)
  4. 3.4 Global Cat Medicines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cat Medicines Major Company Production Sites & Headquarters
  6. 3.6 Global Cat Medicines Company, Product Type & Application
  7. 3.7 Global Cat Medicines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cat Medicines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cat Medicines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cat Medicines Tier 1, Tier 2, and Tier 3
4 Cat Medicines Regional Status and Outlook
  1. 4.1 Global Cat Medicines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cat Medicines Historic Market Size by Region
  3. 4.2.1 Global Cat Medicines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cat Medicines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cat Medicines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cat Medicines Forecasted Market Size by Region
  7. 4.3.1 Global Cat Medicines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cat Medicines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cat Medicines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cat Medicines by Application
  1. 5.1 Cat Medicines Market by Application
  2. 5.1.1 Online
  3. 5.1.2 Offline
  4. 5.2 Global Cat Medicines Market Size by Application
  5. 5.2.1 Global Cat Medicines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Cat Medicines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Cat Medicines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Cat Medicines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Cat Medicines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Cat Medicines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Cat Medicines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Cat Medicines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Wuhan Chopperlvya Animal Health
  2. 6.1.1 Wuhan Chopperlvya Animal Health Company Information
  3. 6.1.2 Wuhan Chopperlvya Animal Health Business Overview
  4. 6.1.3 Wuhan Chopperlvya Animal Health Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Wuhan Chopperlvya Animal Health Cat Medicines Product Portfolio
  6. 6.1.5 Wuhan Chopperlvya Animal Health Recent Developments
  7. 6.2 Zoetis
  8. 6.2.1 Zoetis Company Information
  9. 6.2.2 Zoetis Business Overview
  10. 6.2.3 Zoetis Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Zoetis Cat Medicines Product Portfolio
  12. 6.2.5 Zoetis Recent Developments
  13. 6.3 Tianjin Ringpu Bio-technology
  14. 6.3.1 Tianjin Ringpu Bio-technology Company Information
  15. 6.3.2 Tianjin Ringpu Bio-technology Business Overview
  16. 6.3.3 Tianjin Ringpu Bio-technology Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tianjin Ringpu Bio-technology Cat Medicines Product Portfolio
  18. 6.3.5 Tianjin Ringpu Bio-technology Recent Developments
  19. 6.4 Nanjing Jindun Animal Pharmaceutical
  20. 6.4.1 Nanjing Jindun Animal Pharmaceutical Company Information
  21. 6.4.2 Nanjing Jindun Animal Pharmaceutical Business Overview
  22. 6.4.3 Nanjing Jindun Animal Pharmaceutical Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nanjing Jindun Animal Pharmaceutical Cat Medicines Product Portfolio
  24. 6.4.5 Nanjing Jindun Animal Pharmaceutical Recent Developments
  25. 6.5 Jining Wanhe Biotechnology (Belcol)
  26. 6.5.1 Jining Wanhe Biotechnology (Belcol) Company Information
  27. 6.5.2 Jining Wanhe Biotechnology (Belcol) Business Overview
  28. 6.5.3 Jining Wanhe Biotechnology (Belcol) Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jining Wanhe Biotechnology (Belcol) Cat Medicines Product Portfolio
  30. 6.5.5 Jining Wanhe Biotechnology (Belcol) Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Cat Medicines Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Harbin Pharmaceutical Group
  38. 6.7.1 Harbin Pharmaceutical Group Company Information
  39. 6.7.2 Harbin Pharmaceutical Group Business Overview
  40. 6.7.3 Harbin Pharmaceutical Group Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Harbin Pharmaceutical Group Cat Medicines Product Portfolio
  42. 6.7.5 Harbin Pharmaceutical Group Recent Developments
  43. 6.8 Taizhou Boleideli Biotechnology
  44. 6.8.1 Taizhou Boleideli Biotechnology Company Information
  45. 6.8.2 Taizhou Boleideli Biotechnology Business Overview
  46. 6.8.3 Taizhou Boleideli Biotechnology Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Taizhou Boleideli Biotechnology Cat Medicines Product Portfolio
  48. 6.8.5 Taizhou Boleideli Biotechnology Recent Developments
  49. 6.9 Virbac
  50. 6.9.1 Virbac Company Information
  51. 6.9.2 Virbac Business Overview
  52. 6.9.3 Virbac Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Virbac Cat Medicines Product Portfolio
  54. 6.9.5 Virbac Recent Developments
  55. 6.10 Vetoquinol
  56. 6.10.1 Vetoquinol Company Information
  57. 6.10.2 Vetoquinol Business Overview
  58. 6.10.3 Vetoquinol Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Vetoquinol Cat Medicines Product Portfolio
  60. 6.10.5 Vetoquinol Recent Developments
  61. 6.11 Merck
  62. 6.11.1 Merck Company Information
  63. 6.11.2 Merck Business Overview
  64. 6.11.3 Merck Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Merck Cat Medicines Product Portfolio
  66. 6.11.5 Merck Recent Developments
  67. 6.12 IDEXX
  68. 6.12.1 IDEXX Company Information
  69. 6.12.2 IDEXX Business Overview
  70. 6.12.3 IDEXX Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 IDEXX Cat Medicines Product Portfolio
  72. 6.12.5 IDEXX Recent Developments
  73. 6.13 Elanco
  74. 6.13.1 Elanco Company Information
  75. 6.13.2 Elanco Business Overview
  76. 6.13.3 Elanco Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Elanco Cat Medicines Product Portfolio
  78. 6.13.5 Elanco Recent Developments
  79. 6.14 Dechra Veterinary Products
  80. 6.14.1 Dechra Veterinary Products Company Information
  81. 6.14.2 Dechra Veterinary Products Business Overview
  82. 6.14.3 Dechra Veterinary Products Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Dechra Veterinary Products Cat Medicines Product Portfolio
  84. 6.14.5 Dechra Veterinary Products Recent Developments
  85. 6.15 Ceva
  86. 6.15.1 Ceva Company Information
  87. 6.15.2 Ceva Business Overview
  88. 6.15.3 Ceva Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Ceva Cat Medicines Product Portfolio
  90. 6.15.5 Ceva Recent Developments
  91. 6.16 Boehringer Ingelheim
  92. 6.16.1 Boehringer Ingelheim Company Information
  93. 6.16.2 Boehringer Ingelheim Business Overview
  94. 6.16.3 Boehringer Ingelheim Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Boehringer Ingelheim Cat Medicines Product Portfolio
  96. 6.16.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Cat Medicines Sales by Country
  2. 7.1.1 North America Cat Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cat Medicines Sales by Country (2021-2026)
  4. 7.1.3 North America Cat Medicines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cat Medicines Market Size by Country
  6. 7.2.1 North America Cat Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cat Medicines Market Size by Country (2021-2026)
  8. 7.2.3 North America Cat Medicines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cat Medicines Sales by Country
  2. 8.1.1 Europe Cat Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cat Medicines Sales by Country (2021-2026)
  4. 8.1.3 Europe Cat Medicines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cat Medicines Market Size by Country
  6. 8.2.1 Europe Cat Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cat Medicines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cat Medicines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cat Medicines Sales by Country
  2. 9.1.1 Asia-Pacific Cat Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cat Medicines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cat Medicines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cat Medicines Market Size by Country
  6. 9.2.1 Asia-Pacific Cat Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cat Medicines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cat Medicines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cat Medicines Sales by Country
  2. 10.1.1 South America Cat Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cat Medicines Sales by Country (2021-2026)
  4. 10.1.3 South America Cat Medicines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cat Medicines Market Size by Country
  6. 10.2.1 South America Cat Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cat Medicines Market Size by Country (2021-2026)
  8. 10.2.3 South America Cat Medicines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cat Medicines Sales by Country
  2. 11.1.1 Middle East and Africa Cat Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cat Medicines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cat Medicines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cat Medicines Market Size by Country
  6. 11.2.1 Middle East and Africa Cat Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cat Medicines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cat Medicines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cat Medicines Value Chain Analysis
  2. 12.1.1 Cat Medicines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cat Medicines Production Mode & Process
  7. 12.2 Cat Medicines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cat Medicines Distributors
  10. 12.2.3 Cat Medicines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst